Kairos Pharma Ratios (2024-2025) | KAPA

Ratios Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Dec2025
Profitability
EBT Margin (Quarter) 1,893.75%1,950.00%171.32%-2.89%-2.52%-2.84%
EBIT Margin (Quarter) 1,793.75%1,850.00%71.32%-2.89%-2.53%-2.91%
EBITDA Margin (Quarter) 1,793.75%1,850.00%71.32%-2.89%-2.53%-2.91%
Operating Margin (Quarter) 1,793.75%1,850.00%71.32%-2.89%-2.53%-2.91%
Net Margin (Quarter) 1,893.75%1,950.00%171.32%-2.89%-2.52%-2.84%
FCF Margin (Quarter) -225.00%1,400.00%376.16%-3.61%-1.43%-1.61%
Efficiency
Assets Average (Quarter) 5.39M6.85M7.30M6.61M
Equity Average (Quarter) -2.53M0.34M4.05M5.95M6.56M6.17M
Invested Capital (Quarter) -2.40M-2.65M3.33M4.78M7.13M6.00M6.34M
Asset Utilization Ratio (Quarter) 9.1814.5120.4622.70
Leverage & Solvency
Interest Coverage Ratio (Quarter) -17.94-18.50-0.71
Equity Ratio (Quarter) 0.670.830.900.900.97
Times Interest Earned (Quarter) -17.94-18.50-0.71
Valuation
Enterprise Value (Quarter) -3.22M-3.62M-3.03M-4.49M
Return Ratios
Return on Sales (Quarter) 18.94%19.50%1.71%-0.03%-0.03%-0.03%-0.03%
Return on Capital Employed (Quarter) -0.53%-0.55%-0.69%
Return on Assets (Quarter) -0.54%-0.56%-0.69%-0.63%
Return on Equity (Quarter) -0.72%-0.65%-0.77%-0.67%